Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Clinical trial NCT07311993 · RECRUITING
Trial details
- NCT number
- NCT07311993
- Sponsor
- Cellectar Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2028-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.